End stage lymphoblastic leukemia (ALL) is a type of cancer that affects the white blood cells. It is a type of leukemia that develops from immature white blood cells called lymphoblasts. These immature cells divide in an uncontrolled manner, leading to an accumulation of cancerous cells in the bone marrow and other parts of the body.
End stage lymphoblastic leukemia is the most advanced form of ALL. At this stage, the cancer has spread to other organs, and the patient is at risk of developing severe complications. Symptoms of end stage lymphoblastic leukemia include anemia, fever, weight loss, frequent infections, easy bruising and bleeding, bone and joint pain, and night sweats.
Treatment for end stage lymphoblastic leukemia typically includes chemotherapy, radiation, and stem cell transplant. Chemotherapy is used to reduce the number of cancerous cells, while radiation is used to destroy the cancerous cells that remain. Stem cell transplant is used to replace the cancerous cells with healthy cells from a donor. In some cases, a targeted therapy may also be used to target the specific gene mutations that cause the cancer.
The prognosis for end stage lymphoblastic leukemia is poor, and the survival rate is low. However, with early detection and treatment, many patients can achieve long-term survival. With improved treatments and better understanding of the disease, more patients are being cured of end stage lymphoblastic leukemia.